Do Energy Supplements Actually Work? An Honest Look

Written by the Nuvirox Research Team

Short answer: a few energy supplements do something real, but only under specific conditions, and most of the "energy" you feel from them is just caffeine. The honest map looks like this: stimulants (caffeine) genuinely increase alertness but don't add energy and build tolerance; deficiency-correctors (iron, B12) help meaningfully when you're actually short and barely at all when you're not; and the more interesting compounds (NAD+ precursors, adaptogens like ashwagandha) have real biology and some positive trials, alongside null results that the marketing tends to skip. The useful question isn't "do supplements work?" but "which one matches my actual cause?"

Why do so many energy supplements "work" at first?

Because a lot of them contain caffeine, openly or not. Caffeine reliably increases alertness by blocking adenosine, the molecule that builds sleep pressure, but it doesn't manufacture energy, it lifts the brake (Ferré, 2016). That's why so many "energy" formulas feel effective on day one and fade over weeks: you build tolerance, the same dose does less, and you're often just preventing caffeine withdrawal. If a supplement's lift feels like a coffee, it's probably doing what coffee does, which we cover in why coffee stops working.

Which supplements actually have evidence, and for whom?

Iron is the clearest case, when you're deficient. In a randomized controlled trial, non-anemic menstruating women with low ferritin and unexplained fatigue who took oral iron reported significantly less fatigue than placebo (Vaucher et al., 2012), and an earlier randomized trial found fatigue dropped about 29% with iron versus 13% with placebo in similar women (Verdon et al., 2003). B12 follows the same logic: helpful if you're low (common in vegans, older adults, and people with absorption issues), not a general energizer.

The honest counterweight: no deficiency, no benefit. When non-anemic blood donors with low ferritin but little fatigue were given intravenous iron, their iron stores rose but their fatigue didn't improve versus placebo (Keller et al., 2020). This is the throughline of the whole category: deficiency-correctors help by closing a gap, so if there's no gap, there's little to gain, which is exactly why vitamins often don't help people who weren't short to begin with.

What about adaptogens like ashwagandha?

Adaptogens have a more interesting, genuinely mixed evidence base. In a 12-week randomized, placebo-controlled trial in overweight or mildly obese adults reporting stress and fatigue, an ashwagandha root extract significantly reduced fatigue scores versus placebo, but, tellingly, did not beat placebo on the trial's primary stress measure (Smith et al., 2023). That split is the honest picture: a real signal on one outcome, no effect on another, which is very different from the "clinically proven to crush stress and fatigue" framing you'll see on labels.

Where do NAD+ precursors fit?

NAD+ precursors such as nicotinamide riboside (NR) target the cell's energy machinery, and they reliably do what they say at the biomarker level: NR raised blood NAD+ by roughly 60% at 1,000 mg/day in one crossover trial (Martens et al., 2018) and dose-dependently in a larger study (Conze et al., 2019), with good tolerability. But raising NAD+ is not the same as feeling more energetic. A 2025 randomized trial in people with long-COVID found NR increased NAD+ yet did not significantly improve fatigue versus placebo (Wu et al., 2025). The fair reading: solid, well-tolerated biology and a biomarker effect, with felt-energy benefits still unproven, exactly the kind of honesty the category usually lacks.

So how should you decide?

Match the tool to the cause. If your fatigue might stem from a deficiency, test (ferritin, B12, vitamin D, thyroid) and correct what's actually low, that's where the evidence is strongest. If stress is the driver, an adaptogen might help modestly, with realistic expectations. If you're interested in cellular-energy support, NAD+ precursors are well-tolerated and reliably raise NAD+, framed as a long-term input rather than a stimulant or a guaranteed fatigue fix. And remember the unglamorous truth the supplement aisle won't tell you: sleep, movement, daylight, and steady meals outperform almost every pill for everyday energy.

Frequently asked questions

Do energy supplements actually give you energy?
Most that produce a noticeable lift are relying on caffeine, which increases alertness but doesn't add energy and builds tolerance. The non-stimulant ones mainly help by correcting a deficiency, so they work when you're short and do little when you're not.

Which energy supplement has the best evidence?
For correcting a genuine shortfall, iron (in low-ferritin fatigue) has the clearest trial support, with B12 close behind for deficient people. Their benefit depends on actually being deficient, which is why testing first matters.

Does ashwagandha work for energy?
There's a real but mixed signal. One randomized trial found it reduced fatigue versus placebo while not beating placebo on stress, so it may help modestly, but the evidence doesn't match the sweeping claims on many labels.

Do NAD+ supplements boost energy?
NAD+ precursors like NR reliably raise blood NAD+ and are well tolerated, but a biomarker rise isn't the same as felt energy, and a 2025 long-COVID trial found no significant fatigue benefit versus placebo. Treat them as a long-term cellular-energy input, not a stimulant.

What works better than supplements for energy?
For most people, the basics outperform the bottle: enough good-quality sleep, daily movement (even low-intensity), morning daylight, steady meals, and managing stress. Supplements help most when they fill a specific, confirmed gap.

The bottom line

Do energy supplements work? Some do, narrowly. Stimulants like caffeine increase alertness but build tolerance; deficiency-correctors like iron and B12 genuinely help when you're short and barely when you're not; and the more interesting compounds, NAD+ precursors and adaptogens, have real biology and some supportive trials alongside honest null results. The smart approach is to match the tool to your actual cause, test before you supplement, keep expectations grounded in the trials rather than the labels, and remember that sleep, movement, and daylight beat nearly every pill for day-to-day energy.

References

1. Ferre S. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. Psychopharmacology (Berl). 2016;233(10):1963-1979. DOI: 10.1007/s00213-016-4212-2. PMID: 26786412.
2. Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012;184(11):1247-1254. DOI: 10.1503/cmaj.110950. PMID: 22777991.
3. Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326(7399):1124. DOI: 10.1136/bmj.326.7399.1124. PMID: 12763985.
4. Keller P, von Kanel R, Hincapie CA, et al. The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial. Sci Rep. 2020;10(1):14219. DOI: 10.1038/s41598-020-71048-0. PMID: 32848185.
5. Smith SJ, Lopresti AL, Fairchild TJ. Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 2023;37(11):1091-1104. DOI: 10.1177/02698811231200023. PMID: 37740662.
6. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. DOI: 10.1038/s41467-018-03421-7. PMID: 29599478.
7. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. DOI: 10.1038/s41598-019-46120-z. PMID: 31278280.
8. Wu CY, Reynolds WC, Abril I, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. eClinicalMedicine. 2025;89:103633. DOI: 10.1016/j.eclinm.2025.103633. PMID: 41357333.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.